MedPath

Study of Yili "Changqing" Pro-ABB Yoghurt in the Improvement of Human Gastrointestinal Tract System

Not Applicable
Completed
Conditions
Constipation
Dyspepsia
Flatulence
Abdominal Pain
Registration Number
NCT01682798
Lead Sponsor
Inner Mongolia Yili Industrial Group Co., Ltd
Brief Summary

The purpose of this study is to determine whether Yili "Chang Qing" Pro-ABB yoghurt is effective in improving mild constipation and the intestinal micro-ecology environment \& alimentation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
400
Inclusion Criteria
  1. Male or female subjects, 25-45 yrs;
  2. Non-specific and/or moderate constipation;
  3. Irregular or occasional gastrointestinal disorders (flatulence, gurgling, feeling heavy after eating, abdominal pain);
  4. Slow transit or irregular bowels movements (abnormal feces solidity, bowel movements decreased, e.g. every 2-3 days or less than 3 times per week).
Exclusion Criteria
  1. Diagnosed as chronic constipation;
  2. Treated gastrointestinal symptoms;
  3. Lactose Intolerance;
  4. Treatment by analgesic such as aspirin and paracetamol;
  5. Had laxatives or other remedies to promote digestion 2 weeks prior to the study start;
  6. Consuming dairy products or supplements containing pro/pre-biotic 10 days prior to the study start;
  7. Currently suffering from diarrhea.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in constipation condition after 3 weeksBaseline & 3 weeks
Secondary Outcome Measures
NameTimeMethod
Change in gut resident flora after 3 weeksBaseline & 3 Weeks

Trial Locations

Locations (2)

NanMoFang Community Health Service Center

🇨🇳

ChaoYang District, Beijing, China

JuQuan Community Health Service Center

🇨🇳

Gucun, Baoshan District,, Shanghai, China

NanMoFang Community Health Service Center
🇨🇳ChaoYang District, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath